Decibel Therapeutics amends bylaws to update proxy rules and stockholder meeting procedures

Decibel Therapeutics, Inc.

Eliminated requirement to make stockholder list available during the actual meeting.
Added provisions for adjourning meetings due to technical failure in remote communication.
Enhanced disclosure requirements for stockholder nominations and proposals under universal proxy rules.
Requires evidence of compliance with Rule 14a-19 solicitation requirements at least 5 business days before meeting.
Non-compliant nominations will be disregarded; proxies for such nominees not counted.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Decibel Therapeutics, Inc.: Amended and restated bylaws effective immediately, including changes to stockholder meeting procedures, universal proxy rules, and other updates (effective 2023-04-04).

Change: bylaw amendment
Effective: 2023-04-04

Exact text from the filing

On April 4, 2023, the board of directors (the “Board”) of Decibel Therapeutics, Inc. (the “Company”) approved an amendment and restatement of the Company’s Amended and Restated Bylaws (as so amended and restated, the “Amended and Restated Bylaws”), effective immediately.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0000950170-23-012063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.